Growth hormone affects gene expression and proliferation in human prostate cancer cells

International Journal of Andrology

Volumn 34, Issue 2, 2011, Pages 124-137

  Bidosee, M ^a   Karry, R ^a   Weiss Messer, E ^a   Barkey, R J ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Androgens; Cell proliferation; Gene expression; Growth hormone; Insulin like growth factor axis; Oestrogen receptor isoform; Oestrogens; Prostate cancer cell lines (human); Thyroid hormone

Indexed keywords

ESTRADIOL; ESTRADIOL RECEPTOR; ESTROGEN; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; LIOTHYRONINE; MIBOLERONE; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CYTOLYSIS; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

CELL LINE, TUMOR; ESTRADIOL; GENE EXPRESSION REGULATION; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; NANDROLONE; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RECEPTORS, ESTRADIOL; TRIIODOTHYRONINE;

EID: 79952727031     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2010.01064.x     Document Type: Article

References (36)

1. Angelloz-Nicoud P & Binoux M. (1995) Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136, 5485-5492.
2. Arnold JT, Liu X, Allen JD, Le H, McFann KK & Blackman MR. (2007) Androgen receptor or estrogen receptor-blockade alters DHEA-, DHT-, and E2-induced proliferation and PSA production in human prostate cancer cells. Prostate 67, 1152-1162.
3. Bidosee M, Karry R, Weiss-Messer E & Barkey RJ. (2009) Regulation of growth hormone receptors in human prostate cancer cell lines. Mol Cell Endocrinol 309, 82-92.
4. Bonkhoff H & Berges R. (2009) The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol 55, 533-542.
5. Castagnetta LA, Miceli MD, Sorci CM, Pfeffer U, Farruggio R, Oliveri G, Calabro M & Carruba G. (1995) Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology 136, 2309-2319.
6. Eder IE, Culig Z, Putz T, Nessler-Menardi C, Bartsch G & Klocker H. (2001) Molecular biology of the androgen receptor: from molecular understanding to the clinic. Eur Urol 40, 241-251.
7. Farmer JT & Weigent DA. (2007) Expression of insulin-like growth factor-2 receptors on EL4 lymphoma cells overexpressing growth hormone. Brain Behav Immun 21, 79-85.
8. Friend KE. (2001) Cancer and the potential place for growth hormone receptor antagonist therapy. Growth Horm IGF Res 11(Suppl. A), S121-S123.
9. Gennigens C, Menetrier-Caux C & Droz JP. (2006) Insulin-like growth factor (IGF) family and prostate cancer. Crit Rev Oncol Hematol 58, 124-145.
10. Heemers HV & Tindall DJ. (2007) Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 28, 778-808.
11. Khandwala HM, McCutcheon IE, Flyvbjerg A & Friend KE. (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21, 215-244.
12. Kimura G, Kasuya J, Giannini S, Honda Y, Mohan S, Kawachi M, Akimoto M & Fujita-Yamaguchi Y. (1996) Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int J Urol 3, 39-46.
13. Kleinberg DL, Wood TL, Furth PA & Lee AV. (2009) Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev 30, 51-74.
14. Lau KM, LaSpina M, Long J & Ho SM. (2000) Expression of estrogen receptor (ER)-α and ER-β in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 60, 3175-3182.
15. Meinbach DS & Lokeshwar BL. (2006) Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence? Urol Oncol: Semin Original Invest 24, 294-306.
16. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Lombardi M et al. (2000) Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 19, 5406-5417.
17. Monti S, Proietti-Pannunzi L, Sciarra A, Lolli F, Falasca P, Poggi M, Celi FS & Toscano V. (2007) The IGF axis in prostate cancer. Curr Pharm Des 13, 719-727.
18. Muller AF, Kopchick JJ, Flyvbjerg A & van der Lely AJ. (2004) Growth hormone receptor antagonists. J Clin Endocrinol Metab 89, 1503-1511.
19. Papatsoris AG, Karamouzis MV & Papavassiliou AG. (2005) Novel insights into the implication of the IGF-1 network in prostate cancer. Trends Mol Med 11, 52-55.
20. Perry JK, Emerald BS, Mertani HC & Lobie PE. (2006) The oncogenic potential of growth hormone. Growth Horm IGF Res 16, 277-289.
21. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D & Baserga R. (1993) Inhibition of prostatic cancer cell lines by peptide analogues of insulin-like growth factors. Cancer Res 53, 1102-1106.
22. Prins GS & Korach KS. (2008) The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73, 233-244.
23. Roberts CT, Jr. (2004) IGF-1 and prostate cancer. Novartis Found Symp 262, 193-199; discussion: pp. 199-204 and 265-268.
24. Roberts CT, Jr, Lasky SR, Lowe WL, Jr, Seaman WT & LeRoith D. (1987) Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1, 243-248.
25. Samani AA, Yakar S, LeRoith D & Brodt P. (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28, 20-47.
26. Shen Q, Lantvit DD, Lin Q, Li Y, Christov K, Wang Z, Unterman TG, Mehta RG & Swanson SM. (2007) Advanced rat mammary cancers are growth hormone dependent. Endocrinology 148, 4536-4544.
27. Takahashi Y, Perkins SN, Hursting SD & Wang TT. (2007) 17beta-estradiol differentially regulates androgen-responsive genes through estrogen receptor-beta- and extracellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells. Mol Carcinog 46, 117-129.
28. Tennant MK, Thrasher JB, Twomey PA, Drivdahl RH, Birnbaum RS & Plymate SR. (1996) Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 81, 3774-3782.
29. Untergasser G, Rumpold H, Hermann M, Dirnhofer S, Jilg G & Berger P. (1999) Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors. Exp Gerontol 34, 275-287.
30. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, Jenster G, Berrevoets C, Claassen E, van Rooij HCJ, Trapman J, Brinkmann AO & Mulder E. (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 173, 534-540.
31. Walton GL. (2008) DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. Prostate 68, 210-222.
32. Wang Z, Prins GS, Coschigano KT, Kopchick JJ, Green JE, Ray VH, Hedayat S, Christov KT, Unterman TG & Swanson SM. (2005) Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse. Endocrinology 146, 5188-5196.
33. Waters MJ & Barclay JL. (2007) Does growth hormone drive breast and other cancers? Endocrinology 148, 4533-4535.
34. Weigent DA & Arnold RE. (2005) Expression of insulin-like growth factor-1 and insulin-like growth factor-1 receptors in EL4 lymphoma cells overexpressing growth hormone. Cell Immunol 234, 54-66.
35. Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A & Barkey RJ. (2004) Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Mol Cell Endocrinol 220, 109-123.
36. Yakar S, LeRoith D & Brodt P. (2005) The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: lessons from animal models. Cytokine Growth Factor Rev 16, 407-420.